Efficacy of the Telemedical Lifestyle intervention Program TeLiPro in Advanced Stages of Type 2 Diabetes: A Randomized Controlled Trial.
Source: Kempf, K., et al. 2017 - Pubmed ID: 28500214
Setting: Germany, Attending physician
RCT
Follow up: 52 weeks.
Sample size:
Total: 202 ( 133)
IG: 102 (77)
CG: 100 (56)
Inclusion criteria:
– Diabetes type 2
– Overweight or obese
Home monitoring equipment
– weighing scale
– step counter
– Blood glucose meter.
TeLiPro device (online portal)
– Data upload and Data transfer
Phone call
– Information
– Guidance
Intervention:
Patients monitor and transfer their clinical data via TeLiPro device. Diabetes coaches calls patient weekly for discussion of measured data and for diabetes relevant information
Duration: 12 weeks
Add on: NA
Control group: routine health care visits
Clinical effect:
– HbA1c ↓
– body weight ↓
– BMI ↓
– Bp ↓
– physical health ↑
– Cognitive control ↑
– medication demands ↓
Patient safety:
No adverse events were reported
Patient experiences:
NA
Staff experiences:
NA
Investment:
Home monitoring equipment
– Glucometer
– Weight
– step counter
Running:
Staff resources
– weekly care calls
Organization:
NA
Health care utilization:
NA